**Exhibit 10.13**

 

[Executive]

 

Dear          ;

 

This letter sets forththe arrangement between Abbott Laboratories (“Abbott”), Hospira, Inc.(“Hospira”) and yourself, whereby certain 2004 Hospira benefits shall be paidto you on an after-tax basis and deposited into your existing grantor trust[s]which was [were] previously created, or will be newly created, pursuant to yourparticipation in an Abbott benefit plan and your previous elections thereunder(“Trust”) .

 

During the periodbeginning as of the distribution of Hospira shares to the Abbott stockholders(the “Distribution”) and ending on December 31, 2004 (the “TransitionPeriod”), Hospira shall have in place the Hospira 2004 Performance IncentivePlan, Hospira Supplemental Pension Plan and the Hospira 401(k) SupplementalPlan.  To the extent that you accruebenefits under one or more of these Hospira benefit plans with respect toservices rendered to Hospira during the Transition Period and you previouslyhad, or will have, amounts contributed to your Trust pursuant to correspondingAbbott plans, payments will be made by Hospira to you and deposited into yourexisting Trust, consistent with the 2004 elections you have previously madeunder the corresponding Abbott benefit plans, subject to the provisions of theapplicable Hospira plans.  The amountspaid to your Trust will be net of the maximum taxes required to be withheldfrom the plan payments.  Thecontributions to your Trust will be made in a similar manner as it waspreviously done under the corresponding Abbott plan.

 

Following the Hospirapayment to your Trust, Abbott shall treat such payments as though they weremade pursuant to the corresponding Abbott plan.  Abbott shall remain obligated with respect to all ongoing Trustrelated expenses and shall continue to treat the full balance in the Trust asAbbott plan contributions with respect to annual adjustments and tax gross upcontributions.

 

The transfer of youremployment from Abbott to Hospira in connection with the Distribution shall notconstitute a termination of employment for purposes of distributions under theapplicable Trust.  The “settlementdate,” as that term is used in the Trust documents and applicable paymentelection forms, will occur upon your subsequent retirement or other terminationof employment with Hospira and any reference in such documents to the AbbottLaboratories Annuity Retirement Plan, with respect to the timing ofdistributions, shall be deemed to refer to the Abbott/Hospira TransitionalAnnuity Retirement Plan (“TARP”). Hospira will be obligated to timely notify Abbott of your subsequenttermination of employment and the form of payment of your benefits under theTARP.

 

Each party agrees toexecute such further documents, if any, required by the trustee of the Trust toimplement this agreement.

 

Please sign this letterbelow acknowledging your understanding and agreement with its contents.

 
| ABBOTT  LABORATORIES | HOSPIRA, INC. |
|----------------------|---------------|
|                 |          |
| By:                  |          |   | By: |   |   |
|                 |          |   |   |   |   |
| Its:                 |          |   | Its: |   |   |
|                 |          |
|                 |          |
|                 |          |   |   |   |
| [Executive]          | Date          |   |   |
|                      |               |  |  |  |  |  |  |  |  |

 

----